Featured Research

from universities, journals, and other organizations

New Study Shows Potential To Treat Or Prevent Viral Cancers

Date:
June 18, 2008
Source:
Society of Nuclear Medicine
Summary:
A new study shows that radioimmunotherapy targeting viral antigens offers a novel option to treat -- or even prevent -- many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy.

A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat--or even prevent--many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy.

Related Articles


"There is an urgent need to find new approaches to treating and preventing viral cancers," said Ekaterina (Kate) Dadachova, associate professor of nuclear medicine and microbiology and immunology at Albert Einstein College of Medicine, Bronx, N.Y. and lead researcher of the study, Viral Antigens as Novel Targets for Radioimmunotherapy of Viral Cancers. "The magnitude and global health-burden associated with viral cancers is only now being realized."

It is estimated that up to 25 percent of all cancers are currently linked to existing viral infections. Most of these cancers are extremely difficult to treat and cannot successfully be reduced or removed using conventional therapies or treatments. Viral cancers include cervical cancers caused by infection with a human papillomavirus (HPV), a sexually transmitted disease; hepatocellular carcinoma (HCC), a cancer of the liver; various lymphomas and carcomas in patients with AIDS/HIV; and other cancers.

According to Dadachova, this is the first time that researchers have attempted to target viral antigens on cancers, although the use of RIT for the treatment of cancer has been under development for thirty years. However, the targets of RIT therapy to date have included only "self" human antigens, which are overexpressed on the tumors but also expressed on normal tissues. Viral antigens, on the contrary, are expressed only on the tumors and nowhere else in the body.

The idea to perform the study was suggested by Dr. Arturo Casadevall, chair of the department of microbiology and immunology at Albert Einstein College of Medicine, who collaborates with Dadachova on developing radioimmunotherapy of infectious diseases and cancers. The study involved treating experimental cervical cancer and hepatocellular carcinoma in nude mice with antibodies to respective viral antigens expressed on these tumors.

The antibodies were radiolabeled with 188-Rhenium--a powerful beta-emitting radionuclide. "This study demonstrates a real possibility for more specifically targeted cancer treatments," said Dadachova. "Targeting those antigens with radiolabeled molecules offers exquisite specificity--and will hopefully allow us to significantly increase the efficacy of treatment by administering more individualized doses while avoiding toxicity."

"Nuclear medicine and molecular imaging offer the ability to target disease on a truly molecular level that is unmatched by any other imaging or therapeutic modality," said Dadachova. "Targeting viral antigens with radiolabeled antibodies (or also with specific peptides or aptamers) will allow the extremely precise diagnosis of such cancers and their effective therapy. Furthermore, this approach will make possible 'molecular prevention' of viral cancers, when infected cells will be targeted before they become cancerous."

Dadachova and her team will also be recognized for this study by SNM's Young Professionals' Committee, which recognizes the contributions of significant studies to the fields of nuclear medicine and molecular imaging by young researchers. The Young Professionals' Committee Award will be presented on Sunday, June 15, during a luncheon.

This study was supported by the National Institutes of Health (NIH), Center for AIDS Research (CFAR) and Albert Einstein Cancer Center (AECOM).

Scientific Paper 412: E. Dadachova, X. Wang, E. Revskaya, R.A. Bryan, A. Casadevall, Albert Einstein College of Medicine, Bronx, N.Y., "Viral Antigens as Novel Targets for Radioimmunotherapy of Viral Cancers," SNM's 55th Annual Meeting, June 14-18, 2008.


Story Source:

The above story is based on materials provided by Society of Nuclear Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Society of Nuclear Medicine. "New Study Shows Potential To Treat Or Prevent Viral Cancers." ScienceDaily. ScienceDaily, 18 June 2008. <www.sciencedaily.com/releases/2008/06/080616115744.htm>.
Society of Nuclear Medicine. (2008, June 18). New Study Shows Potential To Treat Or Prevent Viral Cancers. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2008/06/080616115744.htm
Society of Nuclear Medicine. "New Study Shows Potential To Treat Or Prevent Viral Cancers." ScienceDaily. www.sciencedaily.com/releases/2008/06/080616115744.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins